Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-01

Clinical Trial Update: Safety and Efficacy of Ranibizumab for Diabetic Macular Edema [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating the safety and efficacy of ranibizumab for diabetic macular edema with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranibizumab (ranibizumab)

Snippet

Sponsor: Justis Ehlers | Conditions: Diabetic Macular Edema | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-08-01